UNIGE document Scientific Article
previous document  unige:9314  next document
add to browser collection

PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnelles

El Amari, E. B.
Iten, A.
Sacroug, T.
Published in Revue médicale suisse. 2008, vol. 4, no. 152, p. 894-895, 899-900
Abstract Every day, doctors are faced with the dilemma of starting a postexposure prophylaxis (PEP) against HIV, HBV and HCV. A 28 days course of highly active antiretroviral therapy, chosen on the basis of the source's HIV resistance profile, should be initiated, as soon as possible, to reduce the likelihood of HIV transmission. Complete vaccination against HBV (3 doses) is associated with a 100% seroprotection in children and 95% in adults. There is no specific prophylaxis against HCV. Because of the complexity of these situations, we have edited local guidelines, which take into account not only international and Swiss recommendations, but also our experts' opinions. It is important to stress that PEP does not replace standard precautions.
Keywords Anti-Retroviral Agents/therapeutic useAntiviral Agents/therapeutic useHIV Infections/ prevention & controlHepatitis B/ prevention & controlHepatitis B Vaccines/therapeutic useHepatitis C/ prevention & controlHumans
PMID: 18578429
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
(ISO format)
EL AMARI, E. B. et al. PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnelles. In: Revue médicale suisse, 2008, vol. 4, n° 152, p. 894-895, 899-900. https://archive-ouverte.unige.ch/unige:9314

159 hits

0 download


Deposited on : 2010-07-12

Export document
Format :
Citation style :